Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
These shares shall rank pari-passu with the existing equity shares of the Company. Consequent to the aforesaid allotment, the paid-up share capital of the Company has increased from 41,27,28,748 Equity Shares to 41,27,58,490 Equity Shares having face value of Re. 1/- each.
Mankind Pharma Ltd is up for a third straight session in a row. The stock is quoting at Rs 2580.7, up 2.96% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.3% on the day, quoting at 25125.75. The Sensex is at 82155.87, up 0.36%. Mankind Pharma Ltd has dropped around 3.36% in last one month.
Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has dropped around 0.59% in last one month and is currently quoting at 21969.5, up 0.94% on the day. The volume in the stock stood at 8.44 lakh shares today, compared to the daily average of 5.46 lakh shares in last one month.
The benchmark August futures contract for the stock is quoting at Rs 2586.9, up 2.94% on the day. Mankind Pharma Ltd is up 11.26% in last one year as compared to a 1.27% gain in NIFTY and a 1.65% gain in the Nifty Pharma index.
The PE of the stock is 57.14 based on TTM earnings ending June 25.
Mankind Pharma Ltd is down for a fifth straight session today. The stock is quoting at Rs 2435.4, down 1.28% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.45% on the day, quoting at 24473.2. The Sensex is at 80206.91, up 0.44%.Mankind Pharma Ltd has lost around 9.68% in last one month.Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has eased around 3.79% in last one month and is currently quoting at 21402.15, up 0.75% on the day. The volume in the stock stood at 2.26 lakh shares today, compared to the daily average of 6.22 lakh shares in last one month.
The benchmark August futures contract for the stock is quoting at Rs 2451.9, down 0.9% on the day. Mankind Pharma Ltd jumped 13.17% in last one year as compared to a 0.52% rally in NIFTY and a 2.9% fall in the Nifty Pharma index.
The PE of the stock is 56.23 based on TTM earnings ending June 25.